Research funder · United States
Muscular Dystrophy Association
American organization which combats muscular dystrophy
- Grants since 2016
- 438
- Awarded, last 5 years (where amounts are published)
- $37.7M + 1.5M
- Funded works, last 5 years
- 1 011
- Funded works, all time
- 9 236
Grants
2026–2027 · award
Characterization of ANO5 variant expression and localization in skeletal muscle
Ellie Carrell · Virginia Commonwealth University
2026–2029 · award
Somatosensory dysfunction in a Friedreich’s ataxia mouse model.
Jordi Magrane · Weill Cornell Medicine
2026–2028 · research · Research Grant
Modulating ER stress-induced lipotoxicity to ameliorate mitochondrial myopathy
Marilena D'Aurelio · Cornell University
2026–2028 · research · Research Grant
Somatosensory dysfunction in a Friedreich’s ataxia mouse model
Jordi Magrane · Cornell University
2026–2028 · research · Research Grant
LEOPARD-DM2
Chad Heatwole · University of Rochester
2026–2028 · research · Research Grant
In-depth characterization of immune dysfunction in inclusion body myositis
Bhaskar Roy · Yale University
2026 · research · Restricted Research Grant
NY-DMC: Expanding horizons for the diagnoses and treatment of myotonic dystrophy
Andrew Berglund · Research Foundation for the State University of New York
2026–2028 · research · Development Grant
Developing novel chemical and genetic regulators of Stathmin-2 in ALS
Matthew Nolan · Massachusetts General Hospital
2026–2028 · research · Development Grant
Investigating skeletal muscle mediated non-cell autonomous neurodegeneration
Janani Parameswaran · Emory University
2026–2028 · research · Research Grant
Genetic and Extrinsic Mechanisms in Metabolic Myopathies
Vandana Gupta · Brigham and Women's Hospital
2026–2027 · research · Research Grant
SOCE modulation as a potential therapeutic for LGMD R1/2A
Elisabeth Barton · University of Florida
2026–2028 · research · Research Grant
Modeling ALS cortical neuron influences on corticospinal connectivity
Nicholas Maragakis · Johns Hopkins University
2026–2028 · research · Development Grant
Investigating MAM domains and neuronal function in Coenzyme Q10 deficiency
Alba Pesini Martin · Columbia University Irving Medical Center
2026–2028 · research · Research Grant
Advancing treatment for TRPV4 channelopathy
Charlotte Sumner · Johns Hopkins University
2026–2028 · research · Development Grant
MICU1 loss-related myopathy: Role of mitochondrial fusion
Benjamin Cartes Saavedra · Thomas Jefferson University
2026–2028 · research · Research Grant
Molecular Genetics and Therapies for Congenital Myopathies
Alan Beggs · Boston Children's Hospital
2026–2028 · research · Research Grant
Therapeutic Targeting of TAK1 in Duchenne Muscular Dystrophy
Anirban Roy · University of Houston
2026–2027 · award
CRiALS: Clinical Research in ALS
Jonathan Glass · Emory University
2026–2027 · research · MDA Request for Applications
Regenerating healthy human skeletal muscle at single nucleus resolution
Abigail Mackey · Bispebjerg Hospital
2026–2028 · research · Research Grant
Monitoring FSHD with Antibody to SLC34A2
Robert Bloch Ph.D. Harvard University 1972 · University of Maryland, Baltimore
2026 · award
Silence ALS: a platform for the development of individualized ASOs
Neil Shneider · The Trustees Of Columbia University In The City Of New York
2026–2028 · research · Development Grant
The ECM-macrophage axis promotes disease progression in Muscular Dystrophy
Ashlee Long · Northwestern University
2026–2028 · research · Research Grant
A pilot study of Forodesine Treatment for Patients with GUK1 deficiency
Valentina Emmanuele · The Trustees Of Columbia University In The City Of New York
2025–2027 · research · Restricted Research Grant
Molecular and cellular mechanisms of cardiac fibrosis in Friedreich ataxia
Giovanni Manfredi
2025 · research · Restricted Research Grant
Silence ALS: a platform for the development of individualized ASOs
Neil Shneider · The Trustees Of Columbia University In The City Of New York
2025–2026 · research · Restricted Research Grant
Identifying genetic modifiers of TDP43 loss-of-function mediated toxicity (Wings)
Jeffrey Rothstein · Johns Hopkins University
2025–2026 · research · Restricted Research Grant
Gene therapy in a porcine model for DMD
Jeffrey Chamberlain · University of Washington
2025 · research · Restricted Research Grant
NY-DM: Advancing knowledge and practices for myotonic dystrophy (Albany)
Andrew Berglund · Research Foundation for the State University of New York
2025–2027 · research · Restricted Research Grant
Mutation-independent prime editing as a novel therapeutic approach for COL6-RD
Carsten Bonnemann · National Institute of Neurological Disorders and Stroke
2025–2026 · research · Restricted Research Grant
Clinical Research in ALS: CRiALS
Jonathan Glass · Emory University
2025–2026 · research · Restricted Research Grant
Advanced analysis of remote assessments
Johannna Hamel · University of Rochester
2024–2027 · research · Infrastructure Grant
Establishing a global certification standard for evaluating CMT
Joshua Burns · The University of Sydney
2024–2027 · research · Research Grant
Development of optimized transgenes and capsids for treating LGMD2A/R1
Melissa Spencer · The Regents Of The University Of California, Los Angeles
2024–2025 · research · Research Grant
Paired Prime Editors to treat Friedreich’s Ataxia
Jonathan Watts · University of Massachusetts Chan Medical School
2024–2027 · research · Development Grant
The mechanism, synergies, and therapeutic horizon of quercetin in DM and C9-ALS
Subodh Mishra · Research Foundation for the State University of New York
2024–2027 · research · Research Grant
Muscular dystrophy therapy via angiogenesis
Atsushi Asakura · Twin Cities Orthopedics
2024–2027 · research · Research Grant
The role of cholesterol metabolism abnormalities in Coenzyme Q deficiency
Catarina Quinzii · Columbia University Irving Medical Center
2024 · research · Restricted Research Grant
Silence ALS: a platform for the development of individualized ASOs
Neil Shneider · The Trustees Of Columbia University In The City Of New York
2024–2027 · research · Research Grant
Novel type of monogenic diabetes in patients with Welander distal myopathy
Ake Sjoholm · Region Gavleborg
2024–2027 · research · Research Grant
Targeting Sarcolemmal Lipid to Treat Myofiber Death and Degeneration in DMD
Jyoti Jaiswal · Children's Research Institute (cnmc)